158 related articles for article (PubMed ID: 29133667)
1. Methoxsalen-induced macular toxicity.
Maitray A; Rishi P
Indian J Ophthalmol; 2017 Nov; 65(11):1243-1245. PubMed ID: 29133667
[TBL] [Abstract][Full Text] [Related]
2. Lens opacities appearing during therapy with methoxsalen and long-wavelength ultraviolet radiation.
Lafond G; Roy PE; Grenier R
Can J Ophthalmol; 1984 Jun; 19(4):173-5. PubMed ID: 6744101
[TBL] [Abstract][Full Text] [Related]
3. An unusual cause of burn injury: unsupervised use of drugs that contain psoralens.
Türegün M; Oztürk S; Selmanpakoğlu N
J Burn Care Rehabil; 1999; 20(1 Pt 1):50-2. PubMed ID: 9934637
[TBL] [Abstract][Full Text] [Related]
4. Psoralen phototherapy and phototoxicity.
Berakha GJ; Lefkovits G
Ann Plast Surg; 1985 May; 14(5):458-61. PubMed ID: 4083703
[TBL] [Abstract][Full Text] [Related]
5. Methoxsalen-induced advanced bull's eye maculopathy.
Ranjan R; Manayath GJ; Salian R; Narendran V
Eur J Ophthalmol; 2021 May; 31(3):NP70-NP73. PubMed ID: 32064940
[TBL] [Abstract][Full Text] [Related]
6. [Routine monitoring of patients treated with synthetic antimalarials].
Douche C; Bechetoille A; Ebran JM
J Fr Ophtalmol; 1983; 6(8-9):689-95. PubMed ID: 6677659
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral photochemotherapy (8-methoxypsoralen + UVA) on the electrophysiologic function of retina.
Shoeibi N; Taheri A; Nikandish M; Omidtabrizi A; Khosravi N; Kadkhoda M; Moghaddam SG
Cutan Ocul Toxicol; 2016; 35(2):104-9. PubMed ID: 25942691
[TBL] [Abstract][Full Text] [Related]
8. Psoralen photobiology and photochemotherapy: 50 years of science and medicine.
Bethea D; Fullmer B; Syed S; Seltzer G; Tiano J; Rischko C; Gillespie L; Brown D; Gasparro FP
J Dermatol Sci; 1999 Feb; 19(2):78-88. PubMed ID: 10098699
[TBL] [Abstract][Full Text] [Related]
9. Psoralen and bergapten: in silico metabolism and toxicophoric analysis of drugs used to treat vitiligo.
da Silva VB; Kawano DF; Carvalho I; da Conceição EC; de Freitas O; da Silva CH
J Pharm Pharm Sci; 2009; 12(3):378-87. PubMed ID: 20067712
[TBL] [Abstract][Full Text] [Related]
10. Presumed sertraline maculopathy.
Sener EC; Kiratli H
Acta Ophthalmol Scand; 2001 Aug; 79(4):428-30. PubMed ID: 11453869
[TBL] [Abstract][Full Text] [Related]
11. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
Abdel-Naser MB; Hann SK; Bystryn JC
Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
[TBL] [Abstract][Full Text] [Related]
12. [PUVA treatment and the problem of ocular damage (author's transl)].
Lerman S; Koch HR
Klin Monbl Augenheilkd; 1981 May; 178(5):347-9. PubMed ID: 7253523
[TBL] [Abstract][Full Text] [Related]
13. Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial.
El Mofty M; Bosseila M; Mashaly HM; Gawdat H; Makaly H
Clin Exp Dermatol; 2013 Dec; 38(8):830-5. PubMed ID: 23551324
[TBL] [Abstract][Full Text] [Related]
14. Multimodal imaging in a severe case of hydroxychloroquine toxicity.
Bhavsar KV; Mukkamala LK; Freund KB
Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):377-9. PubMed ID: 25856825
[TBL] [Abstract][Full Text] [Related]
15. Macular toxicity and blind spot enlargement during a treatment by voriconazole: A case report.
Mounier A; Agard E; Douma I; Chehab HE; Vie AL; Dot JM; Dot C
Eur J Ophthalmol; 2018 Jul; 28(4):NP11-NP14. PubMed ID: 29623723
[TBL] [Abstract][Full Text] [Related]
16. Macular toxicity secondary to occupational exposure to gold melting.
Almuhtaseb H; Tsokolas G; Lotery A; Jalil A
Eye (Lond); 2019 Oct; 33(10):1667-1669. PubMed ID: 31110231
[No Abstract] [Full Text] [Related]
17. Comparison of two diluents of 1% methoxsalen in the treatment of vitiligo.
Godse KV
Indian J Dermatol Venereol Leprol; 2008; 74(3):298. PubMed ID: 18597981
[No Abstract] [Full Text] [Related]
18. Dermatological and ocular examinations in rabbits chronically photosensitized with methoxsalen.
Parrish JA; Chylack LT; Woehler ME; Cheng HM; Pathak MA; Morison WL; Krugler J; Nelson WF
J Invest Dermatol; 1979 Sep; 73(3):250-5. PubMed ID: 469278
[TBL] [Abstract][Full Text] [Related]
19. Stoichiometric measurement of DNA damage caused by 8-methoxy-psoralen and UVA.
Karikas GA; Schulpis KH; Kokotos G; Michas T; Georgala S
Clin Biochem; 1997 Jul; 30(5):439-42. PubMed ID: 9253522
[No Abstract] [Full Text] [Related]
20. Methoxsalen with ultraviolet A therapy (PUVA).
Rep Carcinog; 2004; 11():III165-6. PubMed ID: 21089901
[No Abstract] [Full Text] [Related]
[Next] [New Search]
